CNTB

0.59006.08%
BG

Brian Gordon Feagan

Member of Scientific Advisory Board

Dr. Brian Gordon Feagan, M.P.H., FRCPC, M.D. is Scientist Emeritus of Robarts Research Institute. Dr. Feagan was Member of Scientific & Clinical Advisory Board of Equillium, Inc. from 2025 until 2026. Dr. Feagan is Scientific Advisor of Granite Bio AG. Dr. Feagan served as Member of Clinical Advisory Board of Palisade Bio, Inc. since December 2024 until 2026. Dr. Feagan was Member of Advisory Board of Enveda Therapeutics, Inc. He serves as Member of Inflammatory Bowel Disease Clinical Advisory Board at Biora Therapeutics, Inc. He was Director of Prometheus Laboratories Inc. since 2024. Dr. Feagan was a Member of Scientific Advisory Board at First Wave BioPharma, Inc. since December 9, 2021 until March 2024. He serves as a Member of Advisory Board - North America at InDex Pharmaceuticals Holding AB (publ). He serves as Director of Robarts Clinical Trials and Professor of Medicine and Epidemiology and Biostatistics at the University of Western Ontario. He is Director at Evida Biosciences Inc. Dr. Feagan is Senior Scientific Director, at Alimentiv Inc, London, Ontario, Canada. Dr. Feagan holds membership in the Canadian and American Association of Gastroenterology, the American College of Gastroenterology, the College of Physicians and Surgeons of Ontario, Crohn?s and Colitis Canada (CCC) and European Crohn?s and Colitis Organization (ECCO). Dr. Feagan serves as Member of Scientific Advisory Board at Connect Biopharma Holdings Limited since January 2021. Dr. Feagan serves as the Member of Scientific Advisory Board at Prometheus Biosciences, Inc. Dr. Feagan is a leading authority in inflammatoy bowel disease. He is a specialist in Internal Medicine with training in Clinical Epidemiology and Gastroenterology. Dr. Feagan was a Scientific Advisor at Funxional Therapeutics Ltd. He worked in the Divisions of Internal Medicine, Clinical Pharmacology and Gastroenterology London Health Sciences Centre, London, United Kingdom and Ontario, Canada and served as Director of Robarts Research Institute, London, United Kingdom and Ontario, Canada. Dr. Feagan serves as Chairperson of Advisory Board at Tillotts Pharma AG. Dr. Feagan is a gastroenterologist with expertise in inflammatory bowel diseases (IBD) including ulcerative colitis and Crohn?s disease. Dr. Feagan has been a Member of Clinical Advisory Board at enGene Therapeutics Inc. (formerly known as enGene Holdings Inc.) (formerly known as enGene, Inc.) since January 24, 2012. He serves as Member of Scientific Advisory Board at Intrexon Actobiotics N.V. (formerly, ActoGeniX). Dr. Feagan serves as a Member of Scientific Advisory Board at Immune Pharmaceuticals, Inc. He serves as Clinical & Scientific Advisor and Consultant at 9 Meters Biopharma, Inc. (formerly, Innovate Biopharmaceuticals, Inc.) Dr. Feagan served as a Member of Scientific Advisory Board of Cosmo Pharmaceuticals N.V. He served as a Member of the Medical Advisory Board of Santarus, Inc. He serves as the Chairman of Scientific Advisory Board of Calypso Biotech SA. He is a Member of the Canadian Association of Gastroenterologist and of the Crohn's and Colitis Foundation of Canada. Dr. Feagan's research efforts focus on the design and implementation of randomized controlled clinical trials and lead investigator on numerous large-scale randomized clinical trials for new IBD treatments. He has authored several book chapters and served as Editor for several books, including Evidence-Based Gastroenterology and Hepatology. Dr. Feagan?s research is very well published in many front ranked peer-reviewed medical journals, including 10 Original Article in New England Journal of Medicine. He served as Member of IBD Clinical Advisory Board at Receptos, Inc. He has authored over 480 articles and book chapters and has given over 600 invited presentations at national and international scientific meetings. His postdoctoral training included a residency in Internal Medicine and a clinical fellowship in Gastroenterology in the Department of Medicine at UWO and postgraduate training in the Department of Epidemiology and Biostatistics at McMaster University, Hamilton, Ontario. A Fellow of the Royal College of Physicians and Surgeons of Canada. He is Member of Clinical Advisory Board of Palisade Bio, Inc. from December 2024. Dr. Feagan has M.D. from The University Of Western Ontario in 1983. Dr. Feagan has M.S. in Medical Microbiology from London School Of Hygiene And Tropical Medicine in 1979. Dr. Feagan has B.S. in Immunology, Bacteriology from The University Of Western Ontario in 1977.

Positions